Hello, is the company's production and sales in the second quarter full? Is there any capacity bottleneck at present? Thank you

Rikeda: Dear investors, thank you for your attention. From March to May, Suzhou and Shanghai successively put forward epidemic prevention and control requirements for personnel and enterprises. In response, the company strictly implemented the epidemic prevention policy and did not achieve full production and sales. The main reason is that employees underwent multiple rounds of nucleic acid testing, which turned continuous production into partially discrete production, affecting the overall production efficiency; some suppliers’ incoming materials were blocked by logistics, causing the company’s overall capacity utilization rate to decline; customers in the epidemic area, their product delivery was delayed due to logistics. Although the epidemic has had an adverse impact on the company’s production and sales, this impact is within the controllable range. The company has actively taken various measures and formulated emergency plans to fully guarantee production and operation. As the epidemic is gradually lifted, the company’s production and sales are expected to continue to increase in June. So far, the company has not encountered a capacity bottleneck. Thank you!